Drug profile · INN
autologous
autologous is an FDA-listed pharmaceutical active ingredient.
Drug details — autologous
- Class
- —
- Route
- —
- Patents
- 8
- Programs
- 70
- Data quality
- 0.70
Quick answer
autologous is an FDA-listed pharmaceutical active ingredient.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| NMPA | clinical trials | — |
Pipeline programs
- Autologous Dendritic Cell-Tumor Cell Immunotherapy (DC-TC)
- Autologous Peripheral Blood Stem Cell injection
- Expanded autologous adipose-derived adult stem cells (eASCs)
- Instant MSC Product accompanying Autologous Chondron Transplantation (IMPACT)
- Suspension of autologous mononuclear cells separated from bone marrow aspirate
- eythrocytapheresis
- Autologous (self) mononuclear cells derived from umbilical cord blood
- Autologous BCMA-targeting CAR T cells
Related patents
-
US 12385010
Gene therapy for recessive dystrophic epidermolysis bullosa using genetically corrected autologous keratinocytes
granted -
US 12186342
Autologous irradiated whole cell tumor vaccines lentivirally engineered to express CD80, IL-15 and IL-15 receptor alpha
granted -
US 12173314
Gene therapy for recessive dystrophic epidermolysis bullosa using genetically corrected autologous keratinocytes
granted -
US 12110504
Gene therapy for recessive dystrophic epidermolysis bullosa using genetically corrected autologous keratinocytes
granted -
US 8852936
Autologous lymph node transfer in combination with VEGF-C or VEGF-D growth factor therapy to treat lymphedema and to improve reconstructive surgery
granted -
US 8541185
Method of predicting responsiveness to autologous adoptive cell transfer therapy
granted -
US 7264820
Cancer immunotherapy using autologous tumor cells combined with cells expressing a membrane cytokline
granted -
US 6277368
Cancer immunotherapy using autologous tumor cells combined with cells expressing a membrane cytokine
expired
Frequently asked questions
What is autologous?
autologous is an FDA-listed pharmaceutical active ingredient.